Companion Diagnostics News on companion diagnostics and drug/test co-development. NGeneBio Receives CE-IVD Mark for NGS-Based Cancer Panel The firm's accompanying software analyzes companion diagnostic biomarkers such as EGFR, BRAF, KRAS, HER2, and ROS1 genes. Illumina, Janssen Biotech Form Strategic Partnership to Develop Precision Medicines The collaboration aims to utilize the sequencing giant's data analytics platforms and lab services to speed up the development of personalized therapies. AmoyDx, AstraZeneca Collaborate to Develop, Commercialize Companion Diagnostic Tests The agreement involves the codevelopment of a CDx to identify prostate cancer patients in China, the European Union, and Japan with HRR gene mutations. FDA Approves FoundationOne CDx for EGFR Inhibitors to Identify EGFR Mutations in NSCLC The FoundationOne CDx test will be used to identify patients for treatment with FDA-approved EGFR inhibitors. Myriad Genetics Launches New Comprehensive Suite of Cancer Tests With Research Registry Premium The company is offering combined germline and somatic cancer testing, and sharing patients' variants identified through that testing in a new research registry. Mar 14, 2022 Guardant Health Gets Japanese Approval for Tumor Mutation Profiling Liquid Biopsy Test Feb 24, 2022 Amoy Diagnostics, Pierre Fabre Collaborate to Develop CDx in China Feb 22, 2022 FDA Approves Foundation Medicine Test as CDx for Merck's Keytruda to Identify MSI-H Solid Tumors Feb 16, 2022 Pharma Startup TenSixteen Bio Developing Drugs, Companion NGS Tests for Clonal Hematopoiesis Premium Feb 16, 2022 Invitae Garners CE-IVD Mark for Two Comprehensive Genomic Profiling Tests Feb 10, 2022 Genetron Health, Hutchmed Partner to Develop CDx for Lung Cancer Tyrosine Kinase Inhibitor Feb 9, 2022 Foundation Medicine, Eli Lilly Ink CDx Development Deal for Retevmo Feb 8, 2022 A2 Biotherapeutics Enrolling Patients in Clinical Study of New CAR-T Therapy Using Tempus NGS Panel Premium Jan 10, 2022 Caris Life Sciences, HotSpot Therapeutics Partner to Develop Precision Medicines, CDx Tests Jan 10, 2022 Grail Partners With Premier's PINC AI to Improve Patient Access to Blood-Based Multi-Cancer Test Dec 10, 2021 Linus Biotechnology Looks to Human 'Exposome' as Biomarker for Autism Spectrum Disorders Test Premium Dec 9, 2021 FDA Approves Thermo Fisher Scientific Oncomine Dx Assay as CDx for Janssen Lung Cancer Drug Dec 9, 2021 Qiagen, Denovo Biopharma to Develop Liquid Biopsy CDx Test for Investigational Lymphoma Treatment Dec 8, 2021 Foundation Medicine Test Nabs FDA Approval as CDx for BRAF Inhibitor Therapeutics for Melanoma Nov 18, 2021 Ikonisys Launches Next Generation of CTC Detection, Analysis Platform; Expands US Presence Premium Nov 18, 2021 Merck, Burning Rock Ink Liquid Biopsy Companion Diagnostics Deal Nov 11, 2021 Sysmex Inostics Sees Ultra-Sensitive Leukemia Liquid Biopsy as Potential CDx Premium Nov 8, 2021 I-Mab, Roche Diagnostics to Codevelop Companion Diagnostics in China Nov 8, 2021 Genetron Health, NeoGenomics Partner on Oncology Drug Clinical Trials and Testing Nov 4, 2021 Burning Rock, Impact Therapeutics Ink Testing Deal for ATR Inhibitor Load More Breaking News Ancient Genome Sequence Provides Look at Ancestry for Individual Who Perished at Pompeii Allogeneic Stem Cell Transplant Outcomes Improve With Diverse Gut Microbes, Immune Cells CorePath Laboratories, Cizzle Biotechnology Partner on Lung Cancer Blood Test Becton Dickinson Gets CE-IVD Mark for High-Throughput COVID/Flu PCR Test QuantuMDx Obtains CE Mark for 30-Minute Multiplex Respiratory Panel Mitochondrial Protein Resource Reveals New Disease Players The Scan Billion-Dollar Diversity Initiative The Howard Hughes Medical Institute is now accepting applications for its new $1.5 billion initiative to boost the diversity of the scientific workforce. Biotech Co-Founder Arrested A co-founder of a Los Angeles-based biotech company has been arrested in connection with a murder-for-hire scheme, according to Endpoint News. Return of the Tasmanian Tiger The Washington Post reports that a team in Australia is working to bring the thylacine back from extinction. Nature Papers on Genome of Individual From Pompeii, CircRNA Study Best Practices, More In Nature this week: first sequenced genome of a person from Pompeii, best practice guidelines for circRNA studies, and more.